lobbying_activities: 592505

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
592505	69efd1d8-6547-4ef0-84c5-da3fdeaf690c	Q1	AMYLIN PHARMACEUTICALS	308536	AMYLIN PHARMACEUTICALS	2008	first_quarter	MED	Comparative Effectiveness Diabetes research issues LHHS appropriations	Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		198000	0	0	2008-04-16T15:04:08-04:00